Novartis opens up a path of research to protect proteins that guard against cancer.

Novartis teams test combinations of targeted therapeutic agents to combat drug resistance in tumors.

Novartis collaborates with Homology Medicines to adapt and refine genome editing technology.

Novartis collaborates with the Banner Alzheimer’s Institute to test treatments for preventing Alzheimer’s disease.

Novartis is developing an experimental drug for weight loss.

Learn how Novartis researchers are working to outsmart tumors.

Learn about the career of our Global Medical Affairs Head for Solid Tumors and Rare Diseases.

Industry labs find that, contrary to earlier evidence, KRAS-driven tumors are not addicted to autophagy.

Novartis researchers are using data to accelerate drug development.